Velocity reports earnings growth in Q2
Real estate finance company Velocity Financial saw its second quarter net income increase and its total loan portfolio grow from 2021 to 2022, according to an earnings statement the company released on Aug. 4. The Westlake Village-based company reported net income of $10.6 million, or diluted earnings per share of 31 cents, in the second Read More →
Amgen to buy ChemoCentryx for $3.7B
Amgen was having a relatively quiet year on the mergers and acquisitions front, at least until Aug. 4, when the Thousand Oaks-based biotech firm announced it will purchase ChemoCentryx for nearly $3.7 billion. ChemoCentryx is a Silicon Valley biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. It has Read More →
Arcutis to raise $150M in public stock offering
Arcutis Biotherapeutics, a Westlake Village-based company developing drugs for immune dermatological conditions, plans to raise $150 million through a public offering of additional shares of common stock. Arcutis announced the pricing of those shares on Aug. 2, at $20 per share. Shares of Arcutis closed at $19.50 that day and then shot up 17% on Read More →
Semtech announces $1.2B Sierra Wireless acquisition
Semtech Corporation, a Camarillo-based semiconductor company specializing in Internet of Things applications, is making its largest acquisition ever, announcing Aug. 2 that it will buy Sierra Wireless for $1.2 billion. Based in Vancouver, Canada, Sierra Wireless also makes components for Internet of Things applications. “Internet of Things” refers to devices connected to the internet that Read More →
Semtech in talks to buy Sierra Wireless for $1.2B
The Camarillo-based semiconductor company Semtech Corp. disclosed Aug. 2 that it “has engaged in advanced discussions” regarding a possible $1.2 billion acquisition of Sierra Wireless, a Canadian company that makes components for the Internet of Things applications that Semtech also specializes in. Bloomberg first reported a potential deal on Aug. 1, and that day shares Read More →
LTC shares up after report of rising earnings for Q2
Westlake Village-based real estate investment trust LTC Properties reported net income of nearly $55 million, or $1.36 per diluted share, for the second quarter ended June 30. That was up from $18.1 million, or 46 cents per diluted share, for the same period last year. Funds from operations attributable to common stockholders were $25.3 million Read More →
Cure sells $20M in intellectual property, replaces CEO and CFO
Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, will be selling a portion of its intellectual property and related assets for $20 million, the company announced July 28. The buyer was a company called TF Tech Ventures, and the deal closed July 22, Cure said in a July 28 filing with the Read More →
